4DBU:
reference: Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer., Chen M, Adeniji AO, Twenter BM, Winkler JD, Christianson DW, Penning TM, Bioorg Med Chem Lett. 2012 Mar 29. PMID: 22507964

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).